What is MiniMed Group 's D&A?

MiniMed Group (MMED) reported D&A of $117M in Q1 2026.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

MiniMed Group MMED D&A

D&A at other companies

MYR GroupMYRG

$16.55M+10.3%

Dave, Inc.DAVE

$1.62M+5.7%

NNN REITNNN

$70.8M+9.6%

Piper SandlerPIPR

$4.73M+12.4%

RepligenRGEN

$19.76M+5.7%

COPT Defense PropertiesCDP

$43.1M+8.0%

Other financials

Income statement

See full

Revenue$790.0M+15.0%

Gross profit$362.0M-8.4%

Operating income-$100.0M-576%

Net income-$119.0M-1,090%

EPS (diluted)-$0.47-1,075%

Balance sheet

See full

Cash & equivalents$10.0M0.0%

Total debt$61.0M—

Total equity$3.5B-0.7%

Total assets$4.3B—

Cash flow

See full

Operating cash flow-$27.0M-147%

CapEx$167.0M+22.8%

Free cash flow-$194.0M-146%

Valuation

See full

Market cap$3.86B—

Returns & leverage

See full

Debt / equity0×—

Current ratio1.6×—

Where this comes from

Reported directly by MiniMed Group in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: MiniMed Group ’s 10-Q, filed April 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiniMed Group 's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MiniMed Group 's D&A?: MiniMed Group (MMED) reported D&A of $117M in Q1 2026.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.